logo
Cats develop dementia just like humans, study finds – here are the key signs to look out for

Cats develop dementia just like humans, study finds – here are the key signs to look out for

Daily Mail​2 days ago
It's a debilitating syndrome that cruelly affects different aspects of cognitive functioning – such as thinking, remembering, and reasoning.
But dementia, which affects about 57 million people worldwide, is not just specific to humans.
Alzheimer's disease, the most common form of dementia, affects cats in the same way it affects humans, a new study reveals.
Scientists at the University of Edinburgh say cats showing dementia symptoms – such as confusion, sleep disruption and more meowing – have brain changes similar to those in people with Alzheimer's.
Studying feline dementia has the potential to help develop human treatments because the condition between the two species is so similar.
And in turn, these treatments could be administered to cats with dementia as well.
'Dementia is a devastating disease – whether it affects humans, cats, or dogs,' said Dr Robert McGeachan, study lead at the University of Edinburgh.
'Our findings highlight the striking similarities between feline dementia and Alzheimer's disease in people.'
Around 50 million people around the world live with Alzheimer's disease – which accounts for between 50 per cent and 70 per cent of dementia cases.
Although the exact cause of Alzheimer's disease is not yet fully understood, it is thought to be caused by the abnormal build–up of proteins in and around brain cells.
In cats, symptoms of dementia include increased meowing, confusion, spatial disorientation, poor grooming habits and disrupted sleep , such as sleeping more than usual or being awake at night.
Other key signs include forgetting that they have just been fed, going to the bathroom outside the litterbox and staring off into space while looking at a wall or corner.
For their study, the University of Edinburgh scientists carried out a post–mortem brain examination on the brains of 25 cats of different ages after they had passed away, including those with signs of dementia.
In the brains of felines with dementia, there was a build–up was found of amyloid–beta, a toxic protein and one of the defining features of Alzheimer's disease, they found.
The dangerous protein clumps together in and around brain cells, first forming small clusters, before eventually accumulating into bulky 'plaques'.
These plaques build up between nerve cells in the brain and disrupt communication between cells, affecting memory, thinking and daily functioning.
Powerful microscopy images also revealed a build–up of amyloid–beta within the synapses – the connections between brain cells – of cats with dementia, as well as older cats.
'We already knew that a toxic protein called amyloid–beta, also seen in human Alzheimer's, builds up in the brains of older cats with dementia,' Dr McGeachan told the Daily Mail.
'What we didn't know was whether it was actually causing damage.
'Our study shows it is – by triggering the brain's immune cells to eat away or engulf the connections between brain cells, called synapses.
'Losing these connections is closely linked to memory and behaviour changes... and it mirrors almost exactly what happens in people with Alzheimer's.'
According to Dr McGeachan and colleagues, cats may also benefit from human–designed Alzheimer's treatments (including recently approved anti–amyloid drugs).
'We can use cats to study the disease and develop treatments that could help both animals and people with dementia,' he added.
The new study, published in the European Journal of Neuroscience, shows that cats are a valuable model for studying dementia in people.
Because of the similarities in the brains of cats and people, scientists could potentially dissect cat brains in the lab to understand more about Alzheimer's in humans.
Previously, researchers have studied genetically modified rodents, but these do not naturally suffer from dementia, so cats may be 'a more accurate model of the disease than traditional laboratory animals', ultimately benefiting both species and their caregivers.
'Feline dementia is so distressing for the cat and for its person,' said Professor Danielle Gunn–Moore, study co–author and expert in feline veterinary medicine at the University of Edinburgh.
'It is by undertaking studies like this that we will understand how best to treat them.
'This will be wonderful for the cats, their owners, people with Alzheimer's and their loved ones.'
HOW TO DETECT ALZHEIMER'S
Alzheimer's disease is a progressive brain disorder that slowly destroys memory, thinking skills and the ability to perform simple tasks.
It is the cause of 60 percent to 70 percent of cases of dementia.
The majority of people with Alzheimer's are age 65 and older.
More than five million Americans have Alzheimer's.
It is unknown what causes Alzheimer's. Those who have the APOE gene are more likely to develop late-onset Alzheimer's.
Signs and symptoms:
Difficulty remembering newly learned information
Disorientation
Mood and behavioral changes
Suspicion about family, friends and professional caregivers
More serious memory loss
Difficulty with speaking, swallowing and walking
Stages of Alzheimer's:
Mild Alzheimer's (early-stage) - A person may be able to function independently but is having memory lapses
Moderate Alzheimer's (middle-stage) - Typically the longest stage, the person may confuse words, get frustrated or angry, or have sudden behavioral changes
Severe Alzheimer's disease (late-stage) - In the final stage, individuals lose the ability to respond to their environment, carry on a conversation and, eventually, control movement
There is no known cure for Alzheimer's, but experts suggest physical exercise, social interaction and adding brain boosting omega-3 fats to your diet to prevent or slowdown the onset of symptoms.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Officials urge caution on mosquito bites abroad amid rise in chikungunya cases
Officials urge caution on mosquito bites abroad amid rise in chikungunya cases

The Independent

timea minute ago

  • The Independent

Officials urge caution on mosquito bites abroad amid rise in chikungunya cases

Health officials have urged people to take precautions against mosquito bites while on holiday amid a rise in cases of chikungunya among travellers returning from abroad. The UK Health Security Agency (UKHSA) has also detected the first cases of the emerging disease oropouche virus in the UK, all of which were linked to travel from Brazil. Chikungunya is a virus spread by mosquito bites, the symptoms of which include a sudden fever and joint pain. According to UKHSA, most people recover within two weeks, although the joint pain can last for months or even years in some cases. Serious complications are not common, but in rare cases the disease can be fatal, particularly in very young or older people, or those with underlying health conditions. The latest travel-associated infections report from UKHSA shows there were 73 cases of chikungunya reported between January and June 2025, compared to 27 cases for the same period last year. The majority were linked to travel to Sri Lanka, India and Mauritius. All cases were reported in England, primarily in London. There is currently no risk of onward transmission of chikungunya, as the two species of mosquito that transmit the disease are not established in the UK, UKHSA said. The illness mainly occurs in Africa and Asia, specifically southern Asia, although cases have been reported in Europe and parts of North America. However, this year there have been outbreaks in the Americas and Asia, with surges in China and the Indian Ocean islands of Reunion, Mayotte and Mauritius. Dr Philip Veal, consultant in public health at UKHSA, said: 'Chikungunya can be a nasty disease and we're seeing a worrying increase in cases among travellers returning to the UK. 'While this mosquito-borne infection is rarely fatal, it can cause severe joint and muscle pain, headaches, sensitivity to light and skin rashes. Thankfully symptoms usually improve within a few weeks, but joint pain may last for months or longer. 'It is essential to take precautions against mosquito bites when travelling. 'Simple steps, such as using insect repellent, covering up your skin and sleeping under insecticide-treated bed nets can greatly reduce the risk.' Two chikungunya vaccines are approved for use in the UK and are available to buy after an assessment at a private travel clinic. Meanwhile, the first UK cases of oropouche virus, which is spread by midge bites, have been detected by UKHSA. The three cases were all associated with travel to Brazil. The flu-like illness can cause a fever, headaches, joint pain, muscle pain, chills, nausea and vomiting. Officials urged anyone who becomes unwell with these symptoms after travel to affected areas, including parts of Central and South America and the Caribbean, to seek urgent medical advice. According to the World Health Organisation (WHO), before late 2023, oropouche virus was mostly reported near the Amazon rainforest area. However, in 2024, Brazil, Bolivia, Colombia, Cuba, Guyana, Peru and the Dominican Republic reported locally transmitted cases of the disease. The UKHSA report also shows a rise in travel-associated cholera cases in the UK, with eight cases in the first half of the year compared to just one in 2024. Most cases were linked with travel to India and Ethiopia. There was also a 67% decrease in the number of dengue cases reported in England, Wales and Northern Ireland from January to June, and there were just four cases of zika virus during the period, down from nine in 2024.

ADHD drugs have wider life benefits, study suggests
ADHD drugs have wider life benefits, study suggests

BBC News

time2 minutes ago

  • BBC News

ADHD drugs have wider life benefits, study suggests

Drug treatment can help people newly diagnosed with ADHD (attention deficit hyperactivity disorder) to reduce their risk of substance misuse, suicidal behaviour, transport accidents and criminality, a study issues are linked to common ADHD symptoms such as acting impulsively and becoming easily 5% of children and 2.5% of adults worldwide are thought to be affected by the disorder - and growing numbers are being findings, published in the British Medical Journal (BMJ), confirm the wider potential benefits of drug treatment and could help patients decide whether to start medication, the researchers say. Having ADHD means the brain works differently to most other people's. Symptoms can include difficulties concentrating and sitting still, having high energy levels and being impulsive. Despite the surge in people asking for help, the disorder is not becoming more common. Last year a BBC investigation found long waits for assessment in the are only diagnosed if the symptoms cause at least a moderate impact on their lives. The most commonly prescribed drugs, called stimulants, help manage everyday symptoms but there has been limited evidence of longer-term benefits for people's behaviour, while well-publicised side-effects, such as headaches, loss of appetite and trouble sleeping, have sparked debate on their safety. This BMJ study was based on 148,500 people aged six to 64, with ADHD in Sweden. Some 57% started drug treatment and, of these, methylphenidate (also known as Ritalin), was prescribed, to 88%.The researchers, from Southampton University and the Karolinska Institute in Stockholm, found taking ADHD medication was linked to reductions of first-time instances of: suicidal behaviour - 17%substance misuse - 15%transport accidents - 12%criminal behaviour - 13%When recurrent events were analysed, the researchers found ADHD medication was linked to reductions of: 15% for suicide attempts25% for substance misuses4% for accidental injuries16% for transport accidents25% for criminal behaviour "Oftentimes there is no information on what the risks are if you don't treat ADHD," said Prof Samuele Cortese, study author and professor of child and adolescent psychiatry at University of Southampton."Now we have evidence they [drugs] can reduce these risks."This could be explained by medication reducing impulsive behaviour and lack of concentration, which might reduce the risk of accidents while driving and reduce aggressive behaviour which could lead to researchers say the study was designed to be as robust as possible but cannot rule out the possibility the results were affected by factors such as people's genes, lifestyles and the severity of their ADHD. Accessing the right medication for ADHD in many countries is not easy, with some drugs in short supply. In the UK waiting times to see specialists after diagnosis in order to access drugs can be several Stuart Kinner, head of the Justice Health Group at Curtin University in Western Australia, said the research demonstrated "the diffuse benefits of ADHD diagnosis and treatment". "Failure to diagnose and treat ADHD can lead to self-medication with alcohol or other drugs, poor mental health, injury, and incarceration," he said. "Too many people with undiagnosed ADHD end up in the criminal justice system, where their condition may remain undiagnosed and untreated."Ian Maidment, professor in clinical pharmacy at Aston University, said the study "adds to our understanding of the potential benefits of these drugs".However, he said the research did not assess whether patients actually took their medication or the impact of different doses.

Cases of killer virus that makes the body ‘fold in on itself' soaring in UK – after virus sparks pandemic fears in China
Cases of killer virus that makes the body ‘fold in on itself' soaring in UK – after virus sparks pandemic fears in China

The Sun

time2 minutes ago

  • The Sun

Cases of killer virus that makes the body ‘fold in on itself' soaring in UK – after virus sparks pandemic fears in China

CASES of a killer virus that can make the body 'fold in on itself' have increased in the UK, health chiefs have warned. There were 73 cases of chikungunya, a mosquito-borne disease that causes crippling joint pain, between January and June 2025 in England, Wales and Northern Ireland - the highest number ever recorded. 5 This is over double the 27 cases reported during the same period in 2024, UK Health Security Agency (UKHSA) data from its most recent travel-associated infection report suggests. The first cases of the oropouche have also been reported in the UK, which were all linked to travel from Brazil. The oropouche virus, dubbed ' sloth fever ', circulates between primates, sloths, and birds in the wild - before it is occasionally passed to humans by midges and mosquitoes. It is primarily found in the Amazon basin in South America, but in recent years has started spreading more widely around the Americas. Health officials have since urged people to take precautions against insect bites while on holiday, as cases of both infections surge. Chikungunya spreads through the bite of infected Aedes mosquitoes, particularly Aedes aegypti and Aedes albopictus species. The virus is rarely deadly, but can cause serious disease spread by the in the very young, older people and those with other underlying illnesses. Typical symptoms include: Excruciating joint pain, which can leave victims hunched or folded over in agony High fever Headache Muscle aches Nausea Fatigue Red, bumpy rash Swelling in the joints, particularly the hands and feet In severe cases, the joint pain can mimic arthritis, leaving sufferers temporarily disabled for months or even years. Oropouche virus The illness mainly occurs in Africa and Asia, specifically southern Asia, although cases have been reported in Europe and parts of North America. However, this year there have been outbreaks in the Americas and Asia, with surges in China and the Indian Ocean islands of Reunion, Mayotte and Mauritius. The majority of UK cases reported this year were linked to travel to Sri Lanka, India and Mauritius. All cases were reported in England, primarily in London. There is currently no risk of onward transmission of chikungunya, as the two species of mosquito that transmit the disease are not established in the UK, UKHSA said. Meanwhile, more than 7,000 people have been struck down by the virus in China since June 2025, according to national health officials. 5 5 The majority of cases have been reported in Foshan, a city in southern Guangdong province, where officials have since rolled out Covid-style lockdowns in a desperate bid to stop the virus from spiralling out of control. At least 12 other cities in the southern Guangdong province have also reported infections. Hong Kong and Taiwan have also reported cases. Dr Philip Veal, consultant in public health at UKHSA, said: "Chikungunya can be a nasty disease and we're seeing a worrying increase in cases among travellers returning to the UK. "While this mosquito-borne infection is rarely fatal, it can cause severe joint and muscle pain, headaches, sensitivity to light and skin rashes. "Thankfully, symptoms usually improve within a few weeks, but joint pain may last for months or longer." He added: "It is essential to take precautions against mosquito bites when travelling. "Simple steps, such as using insect repellent, covering up your skin and sleeping under insecticide-treated bed nets can greatly reduce the risk." Two chikungunya vaccines are approved for use in the UK and are available to buy after an assessment at a private travel clinic. Meanwhile, three cases of oropouche virus have been detected by UKHSA. How concerning is this outbreak in China? Though tactics adopted by authorities in China hark back to lockdown measures five years ago, chikungunya "does not pose the same level of pandemic threat as a virus like Covid-19", according to Prof Tom Solomon, director of The Pandemic Institute in Liverpool. Dr César López-Camacho, from the Jenner Institute at the University of Oxford, added: 'It is extremely unlikely to cause a pandemic in the traditional sense, as chikungunya does not spread from person to person. "However, it can cause large regional outbreaks, especially when introduced to mosquito-rich, low-immunity settings, like what we are probably seeing in China." The risk to the UK from this outbreak is "currently low" as Aedes mosquitoes, which tend to carry the virus, aren't widespread here. "But we do need to watch closely, as climate change and global travel are expanding the range of these mosquitoes, and with it, the viruses they carry," Dr López-Camacho warned. 'It is also important that genetic sequencing of the virus in this outbreak is carried out. "In past outbreaks, mutations have helped chikungunya adapt to new mosquito species. "If the virus has changed, we need to ensure current vaccines still offer protection." Brits travelling to China amidst the outbreak should "be cautious", the disease expert said. He continued: "The US Centre for Disease Control and Prevention has issued a Level 2 travel alert, recommending travellers use insect repellent, wear long sleeves, and stay in screened or air-conditioned accommodation. "Travellers returning from affected areas who develop fever and joint pain should seek medical attention and mention their recent travel." People travelling to high-risk areas where outbreaks of the virus often occur can get vaccinated against chikungunya at a travel clinic. But Prof Solomon noted: "There have been reports of serious side effects in people over the age of 65. "As such, the vaccine is currently recommended for travellers under 65 visiting high-risk areas." The flu-like illness can cause a fever, headaches, joint pain, muscle pain, chills, nausea and vomiting. Officials urged anyone who becomes unwell with these symptoms after travel to affected areas, including parts of Central and South America and the Caribbean, to seek urgent medical advice. According to the World Health Organisation (WHO), before late 2023, oropouche virus was mostly reported near the Amazon rainforest area. However, in 2024, Brazil, Bolivia, Colombia, Cuba, Guyana, Peru and the Dominican Republic reported locally transmitted cases of the disease. The UKHSA report also shows a rise in travel-associated cholera cases in the UK, with eight cases in the first half of the year compared to just one in 2024. Most cases were linked with travel to India and Ethiopia. There was also a 67 per cent decrease in the number of dengue cases reported in England, Wales and Northern Ireland from January to June. And there were just four cases of zika virus during the period, down from nine in 2024. 5 Oropouche virus: Everything you need to know Oropouche fever is a disease caused by Oropouche virus It is spread through the bites of infected midges (small flies) and mosquitoes. Symptoms of Oropouche fever are similar to dengue and include headache, fever, muscle aches, stiff joints, nausea, vomiting, chills, or sensitivity to light. Severe cases may result in brain diseases such as meningitis. Symptoms typically start 4–8 days after being bitten and last 3–6 days. Most people recover without long-term effects. There are no specific medications or vaccines are available. Precautions Travellers heading to affected areas should take steps to avoid bug bites. The virus is endemic in many South American countries, in both rural and urban communities. Outbreaks are periodically reported in Brazil, Bolivia, Colombia, Ecuador, French Guiana, Panama, Peru, and Trinidad and Tobago. Wear tops with long sleeves and long trousers, apply insect repellent regularly, and sleep under a mosquito net if you are not in enclosed, air-conditioned accommodation. Source: US Centre for Disease Control and Prevention

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store